DEF 14A

Company

Iterum Therapeutics plc

Filed

January 2, 2026

Period of Report

January 2, 2026

Accession Number

0001193125-26-001078

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →